http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109045047-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-125 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7024 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-125 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7024 |
| filingDate | 2018-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109045047-B |
| titleOfInvention | Application of crocin composition in preparation of drug for treating Parkinson's disease |
| abstract | The invention provides an application of crocin composition in preparing a medicine for treating Parkinson's disease, and relates to the field of medicines. Researches show that the crocin composition extracted from plants can obviously improve the dyskinesia of mice, increase the number of Tyrosine Hydroxylase (TH) -positive neurons in the substantia nigra of the mice, and simultaneously increase the content of Dopamine (DA) in brain striatum of the mice, and has certain dose dependence. Therefore, the crocin composition has obvious treatment effect on the Parkinson disease model mice caused by MPTP, and the composition has certain anti-Parkinson disease activity. |
| priorityDate | 2018-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 196.